Plain-English translation of NCT07500441 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new way to detect leukemia after you've had a stem cell transplant. Researchers will use a highly sensitive test called digital PCR to look for cancer cells in your bone marrow samples over time. This test is designed to catch any signs of leukemia coming back much earlier than standard methods, so your doctors can act quickly if needed.
After a stem cell transplant, leukemia can sometimes return, but it's hard to catch early with current monitoring methods. This study aims to create a more precise, personalized test that can detect even tiny amounts of cancer cells in your bone marrow, giving doctors a better chance to intervene before leukemia progresses.
You likely qualify if…
You likely don't qualify if…
You will have bone marrow samples collected at several time points over your first year after transplant — at the start and then at months 1, 2, 3, 4.5, 6, 9, and 12. Each sample will be analyzed using the new digital PCR test to track whether any leukemia cells are returning. Your doctors will use the results from these tests to decide if any changes to your care are needed.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China